Cargando…
Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study
OBJECTIVES: To investigate the association of alkaline phosphatase (ALP) levels with the risk of the composite end point of cardiovascular disease (CVD), and all-cause mortality as well as each of them separately. DESIGN: Prospective cohort study. SETTING: Within the framework of the Tehran Lipid an...
Autores principales: | Kabootari, Maryam, Raee, Mohammad Reza, Akbarpour, Samaneh, Asgari, Samaneh, Azizi, Fereidoun, Hadaegh, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254490/ https://www.ncbi.nlm.nih.gov/pubmed/30478120 http://dx.doi.org/10.1136/bmjopen-2018-023735 |
Ejemplares similares
-
Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019) -
Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018) -
Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022) -
Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016) -
Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2020)